Clincosm LogoSign in Get a demo

Mycosis Fungoides

Showing 1 - 25 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

Not yet recruiting
  • Mycosis Fungoides
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2023

Mycosis Fungoides Trial in Istanbul (biopsy)

Recruiting
  • Mycosis Fungoides
  • biopsy
  • Istanbul, Turkey
    Bezmialem Vakif University Hospital
Jun 6, 2023

CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)

Recruiting
  • CTCL
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 18, 2023

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • (no location specified)
May 23, 2023

Interleukin (IL) -35 in Mycosis Fungoides:Case Control Study

Recruiting
  • Mycosis Fungoides
  • Skin biopsy
  • Giza, Egypt
    Cairo University
May 3, 2023

Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)

Not yet recruiting
  • Mycosis Fungoides
  • (no location specified)
Apr 29, 2023

Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

Recruiting
  • Lymphoma, T-Cell, Peripheral
  • +4 more
  • MT-101
  • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
  • Duarte, California
  • +8 more
Jan 27, 2023

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

Recruiting
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
  • THERAKOS® CELLEX photopheresis system
  • New York, New York
    Herbert Irving Pavilion
Dec 23, 2022

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)

Active, not recruiting
  • Mycosis Fungoides
  • +2 more
  • Graz, Austria
  • +53 more
Dec 12, 2022

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • (no location specified)
Dec 7, 2022

Response to Gemcitabine Chemotherapy in Mycosis Fungoides

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides
  • single-arm, non-randomized Biodynamic imaging (BDI)
  • Indianapolis, Indiana
    Indiana University School of Medicine, Department of Dermatology
Nov 16, 2022

Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • +2 more
  • brentuximab vedotin
  • Stanford, California
  • +7 more
Nov 3, 2022

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

Not yet recruiting
  • T-cell Lymphoma
  • +10 more
  • Chicago, Illinois
    Rush University Medical Center
Oct 24, 2022

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Mycosis Fungoides Trial in Houston (Brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • Brentuximab vedotin
  • Houston, Texas
    MD Anderson Cancer Center
Oct 14, 2022

Mycosis Fungoides Trial in Edmonton (Cemiplimab)

Not yet recruiting
  • Mycosis Fungoides
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Sep 12, 2022

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Recruiting
  • Mycosis Fungoides
  • Non-Hodgkin's Lymphoma
    • Duarte, California
    • +12 more
    Jun 17, 2022

    Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

    Recruiting
    • Mycosis Fungoides
    • +2 more
    • Extracorporeal Photopheresis
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital
    Jun 15, 2022

    Localized Skin Lesion, Mycosis Fungoides Trial in Houston (Quality-of-Life Assessment, Questionnaire Administration, Radiation

    Recruiting
    • Localized Skin Lesion
    • Mycosis Fungoides
    • Quality-of-Life Assessment
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 13, 2022

    Mycosis Fungoides Trial in Leiden (Chlormethine)

    Recruiting
    • Mycosis Fungoides
    • Leiden, Netherlands
      Centre for Human Drug Research
    Mar 29, 2022

    Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)

    Recruiting
    • Mycosis Fungoides
    • +12 more
    • Pembrolizumab
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 22, 2022